The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian—but not endometrial cancer

A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer

(2015) S. Stegeman et al.   ENDOCRINE-RELATED CANCER

MDM4SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk

(2015) Liv B. Gansmo et al.   Cancer Medicine

Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649)

(2015) Stian Knappskog et al.   Oncotarget

Influence ofMDM2SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon

(2014) Liv B. Gansmo et al.   INTERNATIONAL JOURNAL OF CANCER

Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility

(2013) Jibing Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

Genetic Susceptibility to Triple-Negative Breast Cancer

(2013) K. N. Stevens et al.   CANCER RESEARCH

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer

(2013) Kristen S. Purrington et al.   CARCINOGENESIS

Genome-wide association studies identify four ER negative–specific breast cancer risk loci

(2013) Montserrat Garcia-Closas et al.   NATURE GENETICS

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

(2013) Rosalind A Eeles et al.   NATURE GENETICS

Correction: Continuous Regional Arterial Infusion with Fluorouracil and Octreotide Attenuates Severe Acute Pancreatitis in a Canine Model

(2013) Meng Tao Zhou et al.   PLoS One

MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer

(2012) Bríd M. Ryan et al.   INTERNATIONAL JOURNAL OF CANCER

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

An integrated map of genetic variation from 1,092 human genomes

(2012)   NATURE

The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians

(2011) Stian Knappskog et al.   CANCER CELL

Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer

(2011) J. Trovik et al.   CLINICAL CANCER RESEARCH

SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer

(2011) Stian Knappskog et al.   EUROPEAN JOURNAL OF CANCER

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

An Illegitimate microRNA Target Site within the 3' UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity

(2010) J. Wynendaele et al.   CANCER RESEARCH

Spontaneous Tumorigenesis in Mice Overexpressing the p53-Negative Regulator Mdm4

(2010) S. Xiong et al.   CANCER RESEARCH

Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis

(2009) Konstantinos P. Economopoulos et al.   BREAST CANCER RESEARCH AND TREATMENT

A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer

(2009) Diptee A. Kulkarni et al.   CARCINOGENESIS

Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene

(2009) G. S. Atwal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA